In addition, IDH2 expression was reduced in some cancers, such as renal [61], gastric [65], and hepatocellular carcinomas [63], and IDH2 inhibited metastatic invasion of gastric and hepatocellular carcinoma cells via matrix metalloproteinases. This evidence concerns the gene IDH2 and cancer.